Position in VTVT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$44,379
-$409 QoQ
Shares Held
1,119
-0.1% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OSAIC HOLDINGS, INC. holds $166,774,546 across 402 Biotechnology names. VTVT ranks #136 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,972 | $19,635,254 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
217,084 | $16,120,657 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
46,653 | $15,436,076 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
183,486 | $11,858,698 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
58,150 | $11,609,647 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,238 | $9,455,565 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
271,608 | $9,022,817 | |
| 8 | ABUS |
Arbutus Biopharma Corp
|
1,348,127 | $6,066,571 |
All Filings in VTVT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,379 | 1,119 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,788 | 1,120 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $37,827 | 1,620 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,550 | 170 | Shares | Defined | 2025-09-04 | |
| 2025-03-31 | $2,632 | 152 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,347 | 170 | Shares | Defined | 2025-06-06 | |
| 2024-09-30 | $2,414 | 178 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,002 | 170 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,529 | 150 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $575 | 50 | Shares | Defined | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||